title: [Almanac 2011: Stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology].
authors.affiliation: Nottingham University Hospitals, Nottingham, UK. robert.henderson@nuh.nhs.uk
authors.forename: Robert A
authors.initials: RA
authors.lastname: Henderson
authors.forename: Adam D
authors.initials: AD
authors.lastname: Timmis
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001552:Benzazepines / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D002309:Cardiology / Q000639:trends*; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000097:blood / Q000175:diagnosis* / Q000628:therapy*; D054855:Drug-Eluting Stents; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D000077550:Ivabradine; D045283:Natriuretic Agents / Q000097:blood; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010879:Piperazines / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D000069458:Ranolazine; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000083:Acetanilides; D000889:Anti-Arrhythmia Agents; D001552:Benzazepines; D015415:Biomarkers; D004791:Enzyme Inhibitors; D045283:Natriuretic Agents; D010879:Piperazines; D020097:Natriuretic Peptide, Brain; D000077550:Ivabradine; D000069458:Ranolazine